Carmichael Hill & Associates’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$312K Sell
2,713
-212
-7% -$24.4K 0.11% 133
2024
Q2
$311K Hold
2,925
0.12% 124
2024
Q1
$283K Hold
2,925
0.11% 136
2023
Q4
$295K Sell
2,925
-103
-3% -$10.4K 0.12% 123
2023
Q3
$308K Hold
3,028
0.14% 112
2023
Q2
$306K Hold
3,028
0.14% 115
2023
Q1
$279K Hold
3,028
0.13% 120
2022
Q4
$275K Sell
3,028
-50
-2% -$4.54K 0.14% 113
2022
Q3
$234K Hold
3,078
0.13% 123
2022
Q2
$260K Sell
3,078
-205
-6% -$17.3K 0.14% 120
2022
Q1
$288K Sell
3,283
-125
-4% -$11K 0.13% 125
2021
Q4
$298K Sell
3,408
-400
-11% -$35K 0.13% 120
2021
Q3
$311K Hold
3,808
0.15% 110
2021
Q2
$347K Sell
3,808
-100
-3% -$9.11K 0.18% 104
2021
Q1
$334K Hold
3,908
0.18% 103
2020
Q4
$369K Hold
3,908
0.22% 89
2020
Q3
$340K Hold
3,908
0.23% 84
2020
Q2
$341K Sell
3,908
-350
-8% -$30.5K 0.25% 79
2020
Q1
$351K Hold
4,258
0.31% 69
2019
Q4
$403K Buy
4,258
+150
+4% +$14.2K 0.29% 70
2019
Q3
$357K Buy
4,108
+100
+2% +$8.69K 0.35% 75
2019
Q2
$366K Sell
4,008
-465
-10% -$42.5K 0.36% 76
2019
Q1
$385K Sell
4,473
-112
-2% -$9.64K 0.4% 69
2018
Q4
$353K Hold
4,585
0.4% 71
2018
Q3
$354K Sell
4,585
-78
-2% -$6.02K 0.34% 76
2018
Q2
$316K Sell
4,663
-446
-9% -$30.2K 0.34% 78
2018
Q1
$370K Sell
5,109
-335
-6% -$24.3K 0.4% 70
2017
Q4
$410K Buy
+5,444
New +$410K 0.45% 68